M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium Journal Article
| Authors: | Sternberg, C. N.; Yagoda, A.; Scher, H. I.; Whitmore Jr, W. F.; Herr, H. W.; Morse, M. J.; Sogani, P. C.; Watson, R. C.; Hollander, P. S.; Fair, W. R. |
| Article Title: | M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium |
| Keywords: | adult; aged; middle aged; clinical trial; mortality; cisplatin; doxorubicin; united states; methotrexate; antineoplastic agent; metastasis; antineoplastic combined chemotherapy protocols; drug administration schedule; bladder tumor; urinary bladder neoplasms; vinblastine; neoplasm metastasis; drug administration; carcinoma, transitional cell; transitional cell carcinoma; clinical trials; m vac protocol; m-vac protocol; humans; human; male; female; article |
| Journal Title: | Progress in Clinical and Biological Research |
| Volume: | 260 |
| ISSN: | 0361-7742 |
| Publisher: | John Wiley & Sons, Inc. |
| Date Published: | 1988-01-01 |
| Start Page: | 481 |
| End Page: | 485 |
| Language: | English |
| PUBMED: | 3283768 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Export Date: 6 August 2020 -- Source: Scopus |
Citation Impact